CORDTREG

Serial Number 88456592
602

Registration Progress

Application Filed
Jun 3, 2019
Under Examination
Approved for Publication
Published for Opposition
Registered

Trademark Image

CORDTREG

Basic Information

Serial Number
88456592
Filing Date
June 3, 2019
Abandonment Date
August 12, 2020
Drawing Code
4000

Status Summary

Current Status
Inactive
Status Code
602
Status Date
Aug 24, 2020
Classes
005

Rights Holder

Abraham J and Phyllis Katz Cord Blood Foundation d/b/a Cleveland Cord Blood Center

99
Address
2500 1 Emery Road, Suite 150
Cleveland, OH 44128

Ownership History

Abraham J and Phyllis Katz Cord Blood Foundation d/b/a Cleveland Cord Blood Center

Original Applicant
99
Cleveland, OH

Legal Representation

Attorney
William L. Warren

USPTO Deadlines

All Deadlines Cleared

All 3 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

14 events
Date Code Type Description Documents
Aug 24, 2020 ABN2 O ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE Loading...
Aug 24, 2020 MAB2 E ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND Loading...
Feb 11, 2020 CNFR R FINAL REFUSAL WRITTEN Loading...
Feb 11, 2020 GNFR O FINAL REFUSAL E-MAILED Loading...
Feb 11, 2020 GNFN O NOTIFICATION OF FINAL REFUSAL EMAILED Loading...
Jan 21, 2020 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Jan 21, 2020 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Jan 21, 2020 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Aug 27, 2019 CNRT R NON-FINAL ACTION WRITTEN Loading...
Aug 27, 2019 GNRT F NON-FINAL ACTION E-MAILED Loading...
Aug 27, 2019 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Aug 23, 2019 DOCK D ASSIGNED TO EXAMINER Loading...
Jun 17, 2019 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Jun 6, 2019 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Pharmaceutical compositions for parenteral delivery containing leukocytes for treating inflammatory, immune, and auto-immune diseases and disorders, including leukemic cancers and graft versus host disease (GVHD)
First Use Anywhere: 0
First Use in Commerce: 0

Additional Information

Pseudo Mark
CORD TREG

Classification

International Classes
005